Status: Not yet recruiting

A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid

This trial is a multicenter randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.

Participants needed: 222

Trial details

Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Ouyi Pharmaceutical Co., Ltd.Updated: Jun 3, 2026

Eligibility criteria

For participants with high risk of ASCVD: LDL-C ≥ 2.6 mmol/L (or 100 mg/dL); [+1]

Known allergy to any component of the investigational drug or its excipients or... [+8]

Status: Recruiting

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia

Exploring the benefit risk ratio of increase in dosage of Zhibitai capsules (2 capsules at a time, 2 times a day) compared to the original dosage (1 capsule at a time, 1 day)

Participants needed: 192

Trial details

Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Chengdu Diao Jiuhong Pharmaceutical FactoryUpdated: Nov 20, 2025Locations: 1

Eligibility criteria

Age between 18 and 75 years old (inclusive), regardless of gender; [+6]

Known or suspected allergy to any component of the investigational product, or h... [+25]

Status: Recruiting

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.

Participants needed: 240

Trial details

Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Gan & Lee Pharmaceuticals.Updated: Jan 17, 2025Locations: 1

Eligibility criteria

1. 18 years and older, male or female. [+3]

1. Known allergy to any component of the investigational drug or its excipients,... [+6]